4-Hydroxypyrimidine-5-carboxylic acid, 95.0%, 250mg

2-Cyanopyridine-3-carboxylic acid, 98%, 250mg

2-Chloro-1-(3,4-difluoro-phenyl)-ethanone, 95.0%, 25g

(R)-tert-Butyl 4-isobutyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 95%, 250mg

(+/-)-Thalidomide>98.0%(HPLC)(N)5g

2-{[4-(chlorosulfonyl)phenyl]formamido}acetic acid, 97%, 250mg

(2-Formyl-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

Tert-butyl 6-((4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 98%, 50mg

2-Bromo-3,6-dichloropyridine, 97%, 500mg

1-(Methylsulfonyl)-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)piperazine, 98%, 500mg

4-(Trifluoromethyl)cyclohexanol (cis- and trans- mixture)>98.0%(GC)5g

Serbatoi di zona Multi, 850 mm, PTFE, acciaio inossidabile 1.4404, 1 pezzo

(S,S)-2,6-Bis(4-isopropyl-2-oxazolin-2-yl)pyridine>98.0%(GC)5g